Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer
Year: 2022
Type: article
Source: Oncogene
Authors: Samikshan Dutta, Navatha Shree Polavaram, Ridwan Islam, Sreyashi Bhattacharya, Sanika Bodas, Thomas Mayr, Sohini Roy, Sophie Alvarez Y. Albala, Marieta I. Toma, Anza Darehshouri, Angelika Borkowetz, Stefanie Conrad, Susanne Fuessel, Manfred Wirth, Gustavo B. Baretton, Lorenz C. Hofbauer, Paramita Ghosh, Kenneth J. Pienta, David L. Klinkebiel, Surinder K. Batra, Michael H. Muders, Kaustubh Datta
Institutions: University of Nebraska Medical Center, University of Bonn, Technische Universität Dresden, University of Nebraska–Lincoln, The University of Texas Southwestern Medical Center, German Cancer Research Center, German Cancer Research Center (DKFZ) Dresden, German Cancer Consortium (DKTK) Dresden, University of California, Davis, Johns Hopkins University, Johns Hopkins Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1098274821, G1646842432, G1719951384, G1856682097, G2910943962, G3448547432, G5168263519, Nuclear Neuropilin2: a novel molecular mediator for aggressive Prostate Cancer, (PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc, Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis, Androgen Receptor-containing novel transcriptional complex for cancer-specific gene expression in therapy-resistant Prostate Cancer, G7464793701, Das Zusammenspiel von GlutaminStoffwechsel und Epigenetik reguliert ProstatakrebsStammzellpopulationen und TumorRadioresistenz, Untersuchung der Rolle einer Neuropilin2/CXCR4 Signalachse bei der Knochenmetastasierung des Prostatakarzinoms
OpenAlex ID: W4283587047